课题基金 / 基金详情

Construction of Tissue Engineered Vascular Autograft and Heart Valve utilizing Biodegradable Scaffold

Construction of Tissue Engineered Vascular Autograft and Heart Valve utilizing Biodegradable Scaffold
利用可生物降解支架构建组织工程自体血管移植物和心脏瓣膜
批准号:
17500317
负责人:
ISHIYAMA Masakuni
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
本研究采用犬骨髓单个核细胞(MN-BMCs)作为支架材料,将其接种于由聚乙交酯纤维和聚(1-丙交酯-co-ε-己内酯)海绵组成的可生物降解管状支架上,构建了组织工程化自体血管(TEVA)和组织工程化心脏瓣膜(TEHV)。在手术当天将该支架植入同一只狗的IVC中。另一方面,将体外培养的混合静脉细胞接种于聚羟基乙酸构建的生物可降解支架上,构建TEHV。植入后对TEVA和TEHV进行生物化学、生物力学和组织学分析,植入后6个月TEVA的生物化学性质和壁厚与自体IVC相似,对静脉压耐受良好,无钙化等问题。这些结果表明,TEVA和TEHV是具有功能性内皮细胞和生物力学性能的生物相容性材料,没有不良副作用。
英文摘要
This study demonstrates the evaluation of tissue-engineered vascular autografts (TEVAs) and Tissue Engineered Heart Valves (TEHV) constructed with autologous mononuclear-bone marrow cells (MN-BMCs) and a biodegradable scaffold using an experimental animal model.MN-BMCs were obtained from a dog and seeded onto a biodegradable tubular scaffold consisting of polyglycolide fiber and poly(1-lactide-co-ε-caprolactone) sponge. This scaffold was implanted in the IVC of the same dog on the day of surgery. On the other hanc, TEHV were constructed with mixed venous cells which were cultured in vitro followed by seeding onto the biodegradable scaffold which was constructed with polyglycolic acid. TEVAs and TEHV were analyzed biochemically, biomechanically and histologically after implantation.TEVAs had similar biochemical properties and wall thickness as native IVC at 6 months after implantation, and tolerated venous pressure well without any problems such as calcification. And TEHV tolerated RV pressure after implantation.These results indicate that TEVAs and TEHV are biocompatible material with functional endothelial cells and biomechanical properties without unwanted side-effects.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
A successful total cavopulmonary connection conversion 13 years after anatomic repair for tricuspid atresia IIc with severe pulmonary resistance
具有严重肺阻力的三尖瓣闭锁 IIc 解剖修复术后 13 年成功完成全腔肺连接转换
DOI: --
发表时间: 2005
期刊: J Thorac Cardiovasc Surg 129
影响因子: --
作者: [Sugimoto K, Kurosawa H, Shin'oka T, Nagatsu M, Morishima S]
通讯作者: Morishima S
Mid-term clinical results of tissue engineered vascular autografts seeded with autologous bome marrow cells
自体骨髓细胞接种组织工程自体血管移植物的中期临床结果
DOI: --
发表时间: 2005
期刊: J Thorac Cardiovasc Surg 129
影响因子: --
作者: [Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa]
通讯作者: Kurosawa
培養人工血管-Tissue Engineering Graft-
培养人工血管-组织工程移植物-
DOI: --
发表时间: 2006
期刊: 分子心血管病 7(5)
影响因子: --
作者: [Toshiki Watanabe, MD, Sadao Omata, PhD, Motoki Odamura, PhD, Masahumi Okada, Phd, Yoshihiko Nakamura, PhD, Hitoshi Yokoyama, MD, Matsumura Goki, 宮本 真嘉, 市原 有起, 保々 恭子]
通讯作者: 保々 恭子
Autopericardial patch tracheoplasty for tracheal stenosis after arterial switch operation
自体心包补片气管成形术治疗动脉调转术后气管狭窄
DOI: --
发表时间: 2005
期刊: J Card Surg 20
影响因子: --
作者: [Takiguchi M, Aoki M, Shin'oka T, Hiramatsu T, Imai Y]
通讯作者: Imai Y
共 12 条
    海外基金